Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era.
Huang C, Tang TL, Qiu YY, Lin YP, Chen SL, Zhao RZ, Shi GQ, Liao SQ, Chen JH, Fu HY, Liu JZ, Xu BH, Liu TB, Yang Y.
Huang C, et al. Among authors: zhao rz.
BMC Cancer. 2024 Jan 13;24(1):72. doi: 10.1186/s12885-024-11837-2.
BMC Cancer. 2024.
PMID: 38218811
Free PMC article.